3-3140611-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182916.3(TRNT1):​c.444G>T​(p.Ala148Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0178 in 1,613,944 control chromosomes in the GnomAD database, including 609 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A148A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.040 ( 242 hom., cov: 34)
Exomes 𝑓: 0.016 ( 367 hom. )

Consequence

TRNT1
NM_182916.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.578

Publications

7 publications found
Variant links:
Genes affected
TRNT1 (HGNC:17341): (tRNA nucleotidyl transferase 1) The protein encoded by this gene is a CCA-adding enzyme which belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. This essential enzyme functions by catalyzing the addition of the conserved nucleotide triplet CCA to the 3' terminus of tRNA molecules. Mutations in this gene result in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
TRNT1 Gene-Disease associations (from GenCC):
  • congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • retinitis pigmentosa and erythrocytic microcytosis
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 3-3140611-G-T is Benign according to our data. Variant chr3-3140611-G-T is described in ClinVar as Benign. ClinVar VariationId is 380599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.578 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRNT1NM_182916.3 linkc.444G>T p.Ala148Ala synonymous_variant Exon 4 of 8 ENST00000251607.11 NP_886552.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRNT1ENST00000251607.11 linkc.444G>T p.Ala148Ala synonymous_variant Exon 4 of 8 1 NM_182916.3 ENSP00000251607.6

Frequencies

GnomAD3 genomes
AF:
0.0393
AC:
5986
AN:
152134
Hom.:
239
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0291
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00366
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.000849
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0133
Gnomad OTH
AF:
0.0411
GnomAD2 exomes
AF:
0.0162
AC:
4063
AN:
251422
AF XY:
0.0140
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0128
Gnomad ASJ exome
AF:
0.00933
Gnomad EAS exome
AF:
0.00288
Gnomad FIN exome
AF:
0.00125
Gnomad NFE exome
AF:
0.0123
Gnomad OTH exome
AF:
0.0132
GnomAD4 exome
AF:
0.0155
AC:
22698
AN:
1461692
Hom.:
367
Cov.:
31
AF XY:
0.0150
AC XY:
10884
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.109
AC:
3658
AN:
33462
American (AMR)
AF:
0.0142
AC:
636
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00953
AC:
249
AN:
26132
East Asian (EAS)
AF:
0.00154
AC:
61
AN:
39678
South Asian (SAS)
AF:
0.00347
AC:
299
AN:
86244
European-Finnish (FIN)
AF:
0.00210
AC:
112
AN:
53410
Middle Eastern (MID)
AF:
0.0137
AC:
79
AN:
5768
European-Non Finnish (NFE)
AF:
0.0148
AC:
16443
AN:
1111898
Other (OTH)
AF:
0.0192
AC:
1161
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
1172
2343
3515
4686
5858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0395
AC:
6015
AN:
152252
Hom.:
242
Cov.:
34
AF XY:
0.0372
AC XY:
2769
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.108
AC:
4491
AN:
41528
American (AMR)
AF:
0.0290
AC:
444
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.00367
AC:
19
AN:
5184
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4822
European-Finnish (FIN)
AF:
0.000849
AC:
9
AN:
10602
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0133
AC:
906
AN:
68026
Other (OTH)
AF:
0.0412
AC:
87
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
269
538
808
1077
1346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0222
Hom.:
61
Bravo
AF:
0.0448
Asia WGS
AF:
0.0220
AC:
75
AN:
3478
EpiCase
AF:
0.0136
EpiControl
AF:
0.0136

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Dec 22, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
6.0
DANN
Benign
0.62
PhyloP100
-0.58
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41399044; hg19: chr3-3182295; API